Showing results (761-770 of 1,155) with videos related to

Sort By:
Pageof 116
Cancer|July 22, 2015
Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimensPhilip A Thompson, Susan M O'Brien, William G Wierda, et al.
The British Journal of Radiology|August 19, 2011
Lowering heart rate with an optimised breathing protocol for prospectively ECG-triggered CT coronary angiographyL Husmann, B A Herzog, A P Pazhenkottil, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 28, 2022
Treatment outcomes and safety in children with rifampicin-resistant TBE Lopez-Varela, A J Garcia-Prats, J A Seddon, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 5, 2018
Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderlyJ A W Hagemans, J Rothbarth, W J Kirkels, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 19, 2026
The predictive role of [177Lu]Lu-PSMA-617 SPECT/CT semiquantitative parameters from the 1st RLT cycle in advanced mCRPC: a preliminary bicentric lesion-based analysisRiccardo Laudicella, Greta Celesti, Matteo Bauckneht, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 4, 2020
The Impact of Different Screening Model Structures on Cervical Cancer Incidence and Mortality Predictions: The Maximum Clinical Incidence Reduction (MCLIR) MethodologyInge M C M de Kok, Emily A Burger, Steffie K Naber, et al.
Gynecologic Oncology|August 1, 1995
Development and characterization of an IL-4-secreting human ovarian carcinoma cell lineA D Santin, G R Ioli, J C Hiserodt, et al.
Gynecologic Oncology|June 12, 2012
Changes in tumor blood flow as measured by Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) may predict activity of single agent bevacizumab in recurrent epithelial ovarian (EOC) and primary peritoneal cancer (PPC) patients: an exploratory analysis of a Gynecologic Oncology Group Phase II studyDana M Chase, Michael W Sill, Bradley J Monk, et al.
Leukemia|December 22, 2019
The BET inhibitor GS-5829 targets chronic lymphocytic leukemia cells and their supportive microenvironmentEkaterina Kim, Elisa Ten Hacken, Mariela Sivina, et al.
Clinical Imaging|January 28, 2017
PET+MR versus PET/CT in the initial staging of head and neck cancer, using a trimodality PET/CT+MR systemTetsuro Sekine, Felipe de Galiza Barbosa, Felix P Kuhn, et al.
Pageof 116